{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:22:59Z","timestamp":1771428179940,"version":"3.50.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI130110"],"award-info":[{"award-number":["AI130110"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL168501"],"award-info":[{"award-number":["HL168501"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL157215"],"award-info":[{"award-number":["HL157215"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL154001"],"award-info":[{"award-number":["HL154001"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68485-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:46:54Z","timestamp":1769708814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9420-1337","authenticated-orcid":false,"given":"Parker J.","family":"Denz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7610-1502","authenticated-orcid":false,"given":"Samuel","family":"Speaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew I.","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana M.","family":"Cable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed K.","family":"Aladhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-559X","authenticated-orcid":false,"given":"Rachael E.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerana R.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Leumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7584-3020","authenticated-orcid":false,"given":"Jack E.","family":"Roettger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miqdad O.","family":"Dhariwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-384X","authenticated-orcid":false,"given":"Estelle","family":"Cormet-Boyaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-658X","authenticated-orcid":false,"given":"Adriana","family":"Forero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-4575","authenticated-orcid":false,"given":"Jacob S.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"68485_CR1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong, N. S. et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet 362, 1353\u20131358 (2003).","journal-title":"Lancet"},{"key":"68485_CR2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953\u20131966 (2003).","journal-title":"N. Engl. J. Med."},{"key":"68485_CR3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3201\/eid1911.131172","volume":"19","author":"ZA Memish","year":"2013","unstructured":"Memish, Z. A. et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 19, 1819\u20131823 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"68485_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","volume":"14","author":"BL Haagmans","year":"2014","unstructured":"Haagmans, B. L. et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 14, 140\u2013145 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"68485_CR5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"68485_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.crimmu.2022.08.003","volume":"3","author":"L Enjuanes","year":"2022","unstructured":"Enjuanes, L. et al. Nature of viruses and pandemics: Coronaviruses. Curr. Res. Immunol. 3, 151\u2013158 (2022).","journal-title":"Curr. Res. Immunol."},{"key":"68485_CR7","first-page":"359","volume":"385","author":"SW Yoon","year":"2014","unstructured":"Yoon, S. W., Webby, R. J. & Webster, R. G. Evolution and ecology of influenza A viruses. Curr. Top. Microbiol. Immunol. 385, 359\u2013375 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"68485_CR8","doi-asserted-by":"crossref","first-page":"e1000012","DOI":"10.1371\/journal.ppat.1000012","volume":"4","author":"MI Nelson","year":"2008","unstructured":"Nelson, M. I. et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4, e1000012 (2008).","journal-title":"PLoS Pathog."},{"key":"68485_CR9","doi-asserted-by":"crossref","first-page":"e1004048","DOI":"10.1371\/journal.ppat.1004048","volume":"10","author":"TM Desai","year":"2014","unstructured":"Desai, T. M. et al. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 10, e1004048 (2014).","journal-title":"PLoS Pathog."},{"key":"68485_CR10","doi-asserted-by":"crossref","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","volume":"9","author":"K Li","year":"2013","unstructured":"Li, K. et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 9, e1003124 (2013).","journal-title":"PLoS Pathog."},{"key":"68485_CR11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15252\/embr.201744100","volume":"18","author":"NM Chesarino","year":"2017","unstructured":"Chesarino, N. M. et al. IFITM3 requires an amphipathic helix for antiviral activity. EMBO Rep. 18, 1740\u20131751 (2017).","journal-title":"EMBO Rep."},{"key":"68485_CR12","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1021\/acsnano.0c10567","volume":"15","author":"X Guo","year":"2021","unstructured":"Guo, X. et al. Interferon-induced transmembrane protein 3 blocks fusion of diverse enveloped viruses by altering mechanical properties of cell membranes. ACS Nano 15, 8155\u20138170 (2021).","journal-title":"ACS Nano"},{"key":"68485_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.chom.2023.03.005","volume":"31","author":"S Klein","year":"2023","unstructured":"Klein, S. et al. IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion. Cell Host Microbe 31, 616\u2013633 e620 (2023).","journal-title":"Cell Host Microbe"},{"key":"68485_CR14","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112234","volume":"42","author":"G Unali","year":"2023","unstructured":"Unali, G. et al. Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity. EMBO J. 42, e112234 (2023).","journal-title":"EMBO J."},{"key":"68485_CR15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519\u2013523 (2012).","journal-title":"Nature"},{"key":"68485_CR16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.4370","volume":"23","author":"EK Allen","year":"2017","unstructured":"Allen, E. K. et al. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat. Med. 23, 975\u2013983 (2017).","journal-title":"Nat. Med."},{"key":"68485_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40588-018-0103-0","volume":"5","author":"A Zani","year":"2018","unstructured":"Zani, A. & Yount, J. S. Antiviral protection by IFITM3 in vivo. Curr. Clin. Microbiol. Rep. 5, 229\u2013237 (2018).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"68485_CR18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1073\/pnas.1321748111","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc. Natl. Acad. Sci. USA 111, 769\u2013774 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68485_CR19","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s10238-023-01038-9","volume":"23","author":"V Pecoraro","year":"2023","unstructured":"Pecoraro, V., Cuccorese, M. & Trenti, T. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFalpha genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis. Clin. Exp. Med. 23, 3251\u20133264 (2023).","journal-title":"Clin. Exp. Med."},{"key":"68485_CR20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fcimb.2017.00294","volume":"7","author":"Y Pan","year":"2017","unstructured":"Pan, Y. et al. IFITM3 Rs12252-C variant increases potential risk for severe influenza virus infection in chinese population. Front. Cell Infect. Microbiol. 7, 294 (2017).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"68485_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/infdis\/jix235","volume":"216","author":"N Lee","year":"2017","unstructured":"Lee, N. et al. IFITM3, TLR3, and CD55 Gene SNPs and cumulative genetic risks for severe outcomes in chinese patients with H7N9\/H1N1pdm09 influenza. J. Infect. Dis. 216, 97\u2013104 (2017).","journal-title":"J. Infect. Dis."},{"key":"68485_CR22","volume":"4","author":"YH Zhang","year":"2013","unstructured":"Zhang, Y. H. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat. Commun. 4, 1418 (2013).","journal-title":"Nat. Commun."},{"key":"68485_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","volume":"222","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J. Infect. Dis. 222, 34\u201337 (2020).","journal-title":"J. Infect. Dis."},{"key":"68485_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12985-017-0884-4","volume":"14","author":"P Mehrbod","year":"2017","unstructured":"Mehrbod, P. et al. Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population. Virol. J. 14, 218 (2017).","journal-title":"Virol. J."},{"key":"68485_CR25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/infdis\/jit468","volume":"209","author":"TC Mills","year":"2014","unstructured":"Mills, T. C. et al. IFITM3 and susceptibility to respiratory viral infections in the community. J. Infect. Dis. 209, 1028\u20131031 (2014).","journal-title":"J. Infect. Dis."},{"key":"68485_CR26","volume":"2","author":"E Cuesta-Llavona","year":"2021","unstructured":"Cuesta-Llavona, E. et al. Association between the interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144 \/ rs12252 haplotypes and COVID-19. Curr. Res. Virol. Sci. 2, 100016 (2021).","journal-title":"Curr. Res. Virol. Sci."},{"key":"68485_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155354","volume":"137","author":"J Gomez","year":"2021","unstructured":"Gomez, J. et al. The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19. Cytokine 137, 155354 (2021).","journal-title":"Cytokine"},{"key":"68485_CR28","volume":"171","author":"PMA Rashid","year":"2023","unstructured":"Rashid, P. M. A. & Salih, G. F. The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients. Cytokine 171, 156349 (2023).","journal-title":"Cytokine"},{"key":"68485_CR29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/vim.2024.0015","volume":"37","author":"SM Elessawy","year":"2024","unstructured":"Elessawy, S. M., Shehab, A., Soliman, D. A., Eldeeb, M. A. & Taha, S. I. Interferon-Induced transmembrane protein-3 Rs12252-G variant increases COVID-19 mortality potential in Egyptian Population. Viral Immunol. 37, 186\u2013193 (2024).","journal-title":"Viral Immunol."},{"key":"68485_CR30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.ygeno.2021.04.002","volume":"113","author":"J Alghamdi","year":"2021","unstructured":"Alghamdi, J. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality. Genomics 113, 1733\u20131741 (2021).","journal-title":"Genomics"},{"key":"68485_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s43162-022-00141-9","volume":"34","author":"S Mulla","year":"2022","unstructured":"Mulla, S. et al. Association of interferon gamma inducible protein-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-1 alpha, interleukin-6, and rs12252 single nucleotide polymorphism of interferon-induced transmembrane protein-3 gene with the severity of COVID-19 infection. Egypt J. Intern Med. 34, 53 (2022).","journal-title":"Egypt J. Intern Med."},{"key":"68485_CR32","doi-asserted-by":"publisher","unstructured":"Kenney, A. D. et al. Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. EMBO Rep. 24, e56660. https:\/\/doi.org\/10.15252\/embr.202256660 (2023).","DOI":"10.15252\/embr.202256660"},{"key":"68485_CR33","doi-asserted-by":"crossref","first-page":"18607","DOI":"10.1073\/pnas.1900784116","volume":"116","author":"AD Kenney","year":"2019","unstructured":"Kenney, A. D. et al. IFITM3 protects the heart during influenza virus infection. Proc. Natl. Acad. Sci. USA 116, 18607\u201318612 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68485_CR34","doi-asserted-by":"crossref","first-page":"e1002909","DOI":"10.1371\/journal.ppat.1002909","volume":"8","author":"CC Bailey","year":"2012","unstructured":"Bailey, C. C., Huang, I. C., Kam, C. & Farzan, M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 8, e1002909 (2012).","journal-title":"PLoS Pathog."},{"key":"68485_CR35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm5371","volume":"8","author":"AD Kenney","year":"2022","unstructured":"Kenney, A. D. et al. Influenza virus replication in cardiomyocytes drives heart dysfunction and fibrosis. Sci. Adv. 8, eabm5371 (2022).","journal-title":"Sci. Adv."},{"key":"68485_CR36","volume":"15","author":"PJ Denz","year":"2024","unstructured":"Denz, P. J. et al. Innate immune control of influenza virus interspecies adaptation via IFITM3. Nat. Commun. 15, 9375 (2024).","journal-title":"Nat. Commun."},{"key":"68485_CR37","doi-asserted-by":"publisher","unstructured":"Thomas P. et al. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein. Preprint at https:\/\/doi.org\/10.1101\/2021.12.31.474653 (2022).","DOI":"10.1101\/2021.12.31.474653"},{"key":"68485_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"68485_CR39","volume":"13","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance. Front. Immunol. 13, 877101 (2022).","journal-title":"Front. Immunol."},{"key":"68485_CR40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"68485_CR41","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03129-23","volume":"15","author":"NS Tanneti","year":"2024","unstructured":"Tanneti, N. S. et al. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. mBio 15, e0312923 (2024).","journal-title":"mBio"},{"key":"68485_CR42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7, 1161\u20131179 (2022).","journal-title":"Nat. Microbiol."},{"key":"68485_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104753","volume":"95","author":"H Shuai","year":"2023","unstructured":"Shuai, H. et al. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine 95, 104753 (2023).","journal-title":"EBioMedicine"},{"key":"68485_CR44","volume":"40","author":"G Shi","year":"2021","unstructured":"Shi, G. et al. Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J. 40, e106501 (2021).","journal-title":"EMBO J."},{"key":"68485_CR45","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085.e1012 (2020).","journal-title":"Cell"},{"key":"68485_CR46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon","year":"2020","unstructured":"Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"68485_CR47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41392-021-00704-2","volume":"6","author":"Z Niu","year":"2021","unstructured":"Niu, Z. et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct. Target Ther. 6, 284 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"68485_CR48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","volume":"9","author":"SY Lau","year":"2020","unstructured":"Lau, S. Y. et al. Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction. Emerg. Microbes Infect. 9, 837\u2013842 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"68485_CR49","doi-asserted-by":"publisher","unstructured":"Liu, Z. et al. Identification of common deletions in the spike protein of severe acute respiratory syndrome Coronavirus 2. J. Virol. 94, 10\u20131128. https:\/\/doi.org\/10.1128\/JVI.00790-20.(2020).","DOI":"10.1128\/JVI.00790-20"},{"key":"68485_CR50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/jgv.0.001453","volume":"101","author":"NS Ogando","year":"2020","unstructured":"Ogando, N. S. et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J. Gen. Virol. 101, 925\u2013940 (2020).","journal-title":"J. Gen. Virol."},{"key":"68485_CR51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.aivir.2016.08.008","volume":"96","author":"EJ Snijder","year":"2016","unstructured":"Snijder, E. J., Decroly, E. & Ziebuhr, J. The nonstructural proteins directing coronavirus rna synthesis and processing. Adv. Virus Res. 96, 59\u2013126 (2016).","journal-title":"Adv. Virus Res."},{"key":"68485_CR52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301689120","volume":"120","author":"SM Bader","year":"2023","unstructured":"Bader, S. M. et al. SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates. Proc. Natl. Acad. Sci. USA 120, e2301689120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68485_CR53","doi-asserted-by":"publisher","unstructured":"Beer, J. et al. Impaired immune response drives age-dependent severity of COVID-19. J. Exp. Med. 219. https:\/\/doi.org\/10.1084\/jem.20220621 (2022).","DOI":"10.1084\/jem.20220621"},{"key":"68485_CR54","doi-asserted-by":"publisher","unstructured":"Gawish, R. et al. ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNgamma-driven immunopathology. Elife 11(2022) https:\/\/doi.org\/10.7554\/eLife.74623 (2022).","DOI":"10.7554\/eLife.74623"},{"key":"68485_CR55","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","journal-title":"Science"},{"key":"68485_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103381","volume":"67","author":"K Huang","year":"2021","unstructured":"Huang, K. et al. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. EBioMedicine 67, 103381 (2021).","journal-title":"EBioMedicine"},{"key":"68485_CR57","doi-asserted-by":"crossref","first-page":"e3001284","DOI":"10.1371\/journal.pbio.3001284","volume":"19","author":"A Muruato","year":"2021","unstructured":"Muruato, A. et al. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. PLoS Biol. 19, e3001284 (2021).","journal-title":"PLoS Biol."},{"key":"68485_CR58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30763-0","volume":"13","author":"R Rathnasinghe","year":"2022","unstructured":"Rathnasinghe, R. et al. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera. Nat. Commun. 13, 3921 (2022).","journal-title":"Nat. Commun."},{"key":"68485_CR59","volume":"12","author":"S Sun","year":"2021","unstructured":"Sun, S. et al. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat. Commun. 12, 5654 (2021).","journal-title":"Nat. Commun."},{"key":"68485_CR60","doi-asserted-by":"publisher","unstructured":"Ueki, H. et al. Development of a mouse-adapted reporter SARS-CoV-2 as a tool for two-photon in vivo imaging. Viruses 16. https:\/\/doi.org\/10.3390\/v16040537 (2024).","DOI":"10.3390\/v16040537"},{"key":"68485_CR61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s42003-024-05878-3","volume":"7","author":"JDS Willett","year":"2024","unstructured":"Willett, J. D. S. et al. SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naive mice. Commun. Biol. 7, 191 (2024).","journal-title":"Commun. Biol."},{"key":"68485_CR62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-022-04630-3","volume":"605","author":"LR Wong","year":"2022","unstructured":"Wong, L. R. et al. Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19. Nature 605, 146\u2013151 (2022).","journal-title":"Nature"},{"key":"68485_CR63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41421-021-00305-x","volume":"7","author":"YN Zhang","year":"2021","unstructured":"Zhang, Y. N. et al. Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2. Cell Discov. 7, 74 (2021).","journal-title":"Cell Discov."},{"key":"68485_CR64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbi.2013.09.006","volume":"35","author":"M Machida","year":"2014","unstructured":"Machida, M. et al. Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB\/cJ and C57BL\/6J mice. Brain Behav. Immun. 35, 125\u2013134 (2014).","journal-title":"Brain Behav. Immun."},{"key":"68485_CR65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart, B. L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12, 123\u2013137 (1988).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"68485_CR66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbi.2021.04.018","volume":"95","author":"S Stutte","year":"2021","unstructured":"Stutte, S. et al. Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice. Brain Behav. Immun. 95, 429\u2013443 (2021).","journal-title":"Brain Behav. Immun."},{"key":"68485_CR67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.185.1.171","volume":"185","author":"P Sarraf","year":"1997","unstructured":"Sarraf, P. et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 185, 171\u2013175 (1997).","journal-title":"J. Exp. Med."},{"key":"68485_CR68","volume":"83","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract. EBioMedicine 83, 104232 (2022).","journal-title":"EBioMedicine"},{"key":"68485_CR69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202012119","volume":"119","author":"MM Eltobgy","year":"2022","unstructured":"Eltobgy, M. M. et al. Caspase-4\/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis. Proc. Natl. Acad. Sci. USA 119, e2202012119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68485_CR70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.2100707","volume":"208","author":"JW Dowling","year":"2022","unstructured":"Dowling, J. W. & Forero, A. Beyond good and evil: molecular mechanisms of type I and III IFN functions. J. Immunol. 208, 247\u2013256 (2022).","journal-title":"J. Immunol."},{"key":"68485_CR71","doi-asserted-by":"publisher","unstructured":"Solstad, A. D. et al. IFN-lambda uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN. JCI Insight 9. https:\/\/doi.org\/10.1172\/jci.insight.171830 (2024).","DOI":"10.1172\/jci.insight.171830"},{"key":"68485_CR72","doi-asserted-by":"publisher","unstructured":"Beyer, D. K. & Forero, A. Mechanisms of antiviral immune evasion of SARS-CoV-2. J. Mol. Biol. 434, 167265. https:\/\/doi.org\/10.1016\/j.jmb.2021.167265 (2022).","DOI":"10.1016\/j.jmb.2021.167265"},{"key":"68485_CR73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00018-024-05131-4","volume":"81","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. The role of fatty acid metabolism in acute lung injury: a special focus on immunometabolism. Cell Mol. Life Sci. 81, 120 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"68485_CR74","doi-asserted-by":"publisher","unstructured":"Carvalho, M. V., Goncalves-de-Albuquerque, C. F. & Silva, A. R. PPAR Gamma: from definition to molecular targets and therapy of lung diseases. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22020805 (2021).","DOI":"10.3390\/ijms22020805"},{"key":"68485_CR75","doi-asserted-by":"crossref","first-page":"63745","DOI":"10.1155\/2007\/63745","volume":"2007","author":"RD Paola","year":"2007","unstructured":"Paola, R. D. & Cuzzocrea, S. Peroxisome proliferator-activated receptors and acute lung injury. PPAR Res. 2007, 63745 (2007).","journal-title":"PPAR Res."},{"key":"68485_CR76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2012.10.016","volume":"28","author":"PK Gajendrareddy","year":"2013","unstructured":"Gajendrareddy, P. K. et al. MMP-8 overexpression and persistence of neutrophils relate to stress-impaired healing and poor collagen architecture in mice. Brain Behav. Immun. 28, 44\u201348 (2013).","journal-title":"Brain Behav. Immun."},{"key":"68485_CR77","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.1016\/S0021-9258(19)38413-3","volume":"265","author":"KA Hasty","year":"1990","unstructured":"Hasty, K. A. et al. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265, 11421\u201311424 (1990).","journal-title":"J. Biol. Chem."},{"key":"68485_CR78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.cr.7290028","volume":"9","author":"D Pei","year":"1999","unstructured":"Pei, D. Leukolysin\/MMP25\/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res. 9, 291\u2013303 (1999).","journal-title":"Cell Res."},{"key":"68485_CR79","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/msb.134947","volume":"10","author":"Z Altboum","year":"2014","unstructured":"Altboum, Z. et al. Digital cell quantification identifies global immune cell dynamics during influenza infection. Mol. Syst. Biol. 10, 720 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"68485_CR80","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/JVI.02974-15","volume":"90","author":"A Forero","year":"2015","unstructured":"Forero, A. et al. The 1918 influenza virus PB2 protein enhances virulence through the disruption of inflammatory and wnt-mediated signaling in mice. J. Virol. 90, 2240\u20132253 (2015).","journal-title":"J. Virol."},{"key":"68485_CR81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300474120","volume":"120","author":"JP Stumpff","year":"2023","unstructured":"Stumpff, J. P. et al. Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes. Proc. Natl. Acad. Sci. USA 120, e2300474120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68485_CR82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748097","volume":"12","author":"I Sieminska","year":"2021","unstructured":"Sieminska, I. et al. Mild and asymptomatic COVID-19 convalescents present long-term endotype of immunosuppression associated with neutrophil subsets possessing regulatory functions. Front. Immunol. 12, 748097 (2021).","journal-title":"Front. Immunol."},{"key":"68485_CR83","doi-asserted-by":"publisher","unstructured":"Zheng, J. et al. CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection. J. Clin. Investig. 135. https:\/\/doi.org\/10.1172\/JCI188222 (2025).","DOI":"10.1172\/JCI188222"},{"key":"68485_CR84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5795","volume":"14","author":"PM George","year":"2022","unstructured":"George, P. M. et al. A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Sci. Transl. Med. 14, eabo5795 (2022).","journal-title":"Sci. Transl. Med."},{"key":"68485_CR85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2022.01.017","volume":"55","author":"B Vijayakumar","year":"2022","unstructured":"Vijayakumar, B. et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 55, 542\u2013556 e545 (2022).","journal-title":"Immunity"},{"key":"68485_CR86","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/imr.13154","volume":"314","author":"WM Nauseef","year":"2023","unstructured":"Nauseef, W. M. Human neutrophils not equal murine neutrophils: Does it matter? Immunol. Rev. 314, 442\u2013456 (2023).","journal-title":"Immunol. Rev."},{"key":"68485_CR87","doi-asserted-by":"publisher","unstructured":"Thwaites, R. S. et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci. Immunol. 6. https:\/\/doi.org\/10.1126\/sciimmunol.abg9873 (2021).","DOI":"10.1126\/sciimmunol.abg9873"},{"key":"68485_CR88","doi-asserted-by":"publisher","unstructured":"Moussavi-Harami, S. F. et al. Neutrophil-specific Shp1 loss results in lethal pulmonary hemorrhage in mouse models of acute lung injury. J. Clin. Investig. 134. https:\/\/doi.org\/10.1172\/JCI183161 (2024).","DOI":"10.1172\/JCI183161"},{"key":"68485_CR89","doi-asserted-by":"publisher","unstructured":"Xu, F. et al. IFITM3 Inhibits SARS-CoV-2 infection and is associated with COVID-19 susceptibility. Viruses 14. https:\/\/doi.org\/10.3390\/v14112553 (2022).","DOI":"10.3390\/v14112553"},{"key":"68485_CR90","doi-asserted-by":"publisher","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370. https:\/\/doi.org\/10.1126\/science.abd4570 (2020).","DOI":"10.1126\/science.abd4570"},{"key":"68485_CR91","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24521-x","volume":"12","author":"R Robinot","year":"2021","unstructured":"Robinot, R. et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat. Commun. 12, 4354 (2021).","journal-title":"Nat. Commun."},{"key":"68485_CR92","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s13238-020-00752-4","volume":"11","author":"J He","year":"2020","unstructured":"He, J. et al. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients. Protein Cell 11, 680\u2013687 (2020).","journal-title":"Protein Cell"},{"key":"68485_CR93","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112204","volume":"395","author":"G Nunnari","year":"2020","unstructured":"Nunnari, G. et al. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Exp. Cell Res. 395, 112204 (2020).","journal-title":"Exp. Cell Res."},{"key":"68485_CR94","doi-asserted-by":"publisher","unstructured":"Gutman, H. et al. Matrix metalloproteinases expression is associated with SARS-CoV-2-induced lung pathology and extracellular-matrix remodeling in K18-hACE2 Mice. Viruses 14. https:\/\/doi.org\/10.3390\/v14081627 (2022).","DOI":"10.3390\/v14081627"},{"key":"68485_CR95","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jgg.2021.12.003","volume":"48","author":"C Wei","year":"2021","unstructured":"Wei, C. et al. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J. Genet Genom. 48, 1111\u20131121 (2021).","journal-title":"J. Genet Genom."},{"key":"68485_CR96","doi-asserted-by":"publisher","unstructured":"Liu, W. et al. Evolution of the SARS-CoV-2 omicron variants: genetic impact on viral fitness. Viruses 16. https:\/\/doi.org\/10.3390\/v16020184 (2024).","DOI":"10.3390\/v16020184"},{"key":"68485_CR97","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","volume":"602","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature 602, 294\u2013299 (2022).","journal-title":"Nature"},{"key":"68485_CR98","doi-asserted-by":"publisher","unstructured":"Soveg, F. W. et al. Endomembrane targeting of human OAS1 p46 augments antiviral activity. Elife 10. https:\/\/doi.org\/10.7554\/eLife.71047 (2021).","DOI":"10.7554\/eLife.71047"},{"key":"68485_CR99","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj3624","volume":"374","author":"A Wickenhagen","year":"2021","unstructured":"Wickenhagen, A. et al. A prenylated dsRNA sensor protects against severe COVID-19. Science 374, eabj3624 (2021).","journal-title":"Science"},{"key":"68485_CR100","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/cmi.12262","volume":"16","author":"R Jia","year":"2014","unstructured":"Jia, R. et al. Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol. 16, 1080\u20131093 (2014).","journal-title":"Cell Microbiol."},{"key":"68485_CR101","doi-asserted-by":"crossref","first-page":"11986","DOI":"10.1074\/jbc.M114.557694","volume":"289","author":"NM Chesarino","year":"2014","unstructured":"Chesarino, N. M., McMichael, T. M., Hach, J. C. & Yount, J. S. Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J. Biol. Chem. 289, 11986\u201311992 (2014).","journal-title":"J. Biol. Chem."},{"key":"68485_CR102","doi-asserted-by":"crossref","first-page":"19631","DOI":"10.1074\/jbc.M112.362095","volume":"287","author":"JS Yount","year":"2012","unstructured":"Yount, J. S., Karssemeijer, R. A. & Hang, H. C. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287, 19631\u201319641 (2012).","journal-title":"J. Biol. Chem."},{"key":"68485_CR103","doi-asserted-by":"crossref","first-page":"e1005095","DOI":"10.1371\/journal.ppat.1005095","volume":"11","author":"NM Chesarino","year":"2015","unstructured":"Chesarino, N. M., McMichael, T. M. & Yount, J. S. E3 Ubiquitin Ligase NEDD4 promotes influenza virus infection by decreasing levels of the antiviral protein IFITM3. PLoS Pathog. 11, e1005095 (2015).","journal-title":"PLoS Pathog."},{"key":"68485_CR104","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nchembio.405","volume":"6","author":"JS Yount","year":"2010","unstructured":"Yount, J. S. et al. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 6, 610\u2013614 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"68485_CR105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167759","volume":"434","author":"K Rahman","year":"2022","unstructured":"Rahman, K. et al. Cholesterol binds the amphipathic helix of IFITM3 and regulates antiviral activity. J. Mol. Biol. 434, 167759 (2022).","journal-title":"J. Mol. Biol."},{"key":"68485_CR106","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s44318-024-00334-8","volume":"44","author":"K Rahman","year":"2025","unstructured":"Rahman, K. et al. SNARE mimicry by the CD225 domain of IFITM3 enables regulation of homotypic late endosome fusion. Embo J. 44, 534\u2013562 (2025).","journal-title":"Embo J."},{"key":"68485_CR107","volume":"16","author":"PJ Denz","year":"2025","unstructured":"Denz, P. J. & Yount, J. S. IFITM3 variants point to a critical role in emergent virus infections. mBio 16, e0334724 (2025).","journal-title":"mBio"},{"key":"68485_CR108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36735-z","volume":"9","author":"RE Rayner","year":"2019","unstructured":"Rayner, R. E., Makena, P., Prasad, G. L. & Cormet-Boyaka, E. Optimization of normal human Bronchial Epithelial (NHBE) Cell 3D cultures for in vitro lung model studies. Sci. Rep. 9, 500 (2019).","journal-title":"Sci. Rep."},{"key":"68485_CR109","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12013-021-01042-4","volume":"80","author":"RE Rayner","year":"2022","unstructured":"Rayner, R. E. et al. Transcriptomic response of primary human bronchial cells to repeated exposures of cigarette and ENDS Preparations. Cell Biochem. Biophys. 80, 217\u2013228 (2022).","journal-title":"Cell Biochem. Biophys."},{"key":"68485_CR110","doi-asserted-by":"crossref","first-page":"L518","DOI":"10.1152\/ajplung.00317.2022","volume":"325","author":"MY Chang","year":"2023","unstructured":"Chang, M. Y., Brune, J. E., Black, M., Altemeier, W. A. & Frevert, C. W. Multicompartmental analysis of the murine pulmonary immune response by spectral flow cytometry. Am. J. Physiol. Lung Cell Mol. Physiol. 325, L518\u2013L535 (2023).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"68485_CR111","doi-asserted-by":"publisher","unstructured":"Dhariwala, M. O. et al. Commensal myeloid crosstalk in neonatal skin regulates cutaneous type 17 inflammation. Preprint at https:\/\/doi.org\/10.1101\/2023.09.29.560039 (2025).","DOI":"10.1101\/2023.09.29.560039"},{"key":"68485_CR112","first-page":"291","volume":"23","author":"AC Ruifrok","year":"2001","unstructured":"Ruifrok, A. C. & Johnston, D. A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291\u2013299 (2001).","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"68485_CR113","doi-asserted-by":"publisher","unstructured":"Crowe, A. R. & Yue, W. Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio Protoc. 9. https:\/\/doi.org\/10.21769\/BioProtoc.3465 (2019).","DOI":"10.21769\/BioProtoc.3465"},{"key":"68485_CR114","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47067-0","volume":"15","author":"S Speaks","year":"2024","unstructured":"Speaks, S. et al. Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation. Nat. Commun. 15, 2751 (2024).","journal-title":"Nat. Commun."},{"key":"68485_CR115","doi-asserted-by":"crossref","first-page":"e1004856","DOI":"10.1371\/journal.pcbi.1004856","volume":"12","author":"Y Steuerman","year":"2016","unstructured":"Steuerman, Y. & Gat-Viks, I. Exploiting gene-expression deconvolution to probe the genetics of the immune system. PLoS Comput. Biol. 12, e1004856 (2016).","journal-title":"PLoS Comput. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68485-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:48:32Z","timestamp":1771426112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68485-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68485"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68485-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1779"}}